Follow us on Twitter
twitter icon@FreshPatents

Browse patents:
Next
Prev

Serum diagnostic method, biomarker and kit for early detection and staging of alzheimer's disease




Title: Serum diagnostic method, biomarker and kit for early detection and staging of alzheimer's disease.
Abstract: A laboratory method for screening, diagnosing, monitoring and/or staging early onset Alzheimer's disease which consists of mild cognitive impairment entails conducting a blood test after an oxidative exposure of serum to assay for the presence of an elevated level of redox-reactive autoantibodies. ...


USPTO Applicaton #: #20120107841
Inventors: John A. Mcintyre


The Patent Description & Claims data below is from USPTO Patent Application 20120107841, Serum diagnostic method, biomarker and kit for early detection and staging of alzheimer's disease.




← Previous       Next →
Advertise on FreshPatents.com - Rates & Info


You can also Monitor Keywords and Search for tracking patents relating to this Serum diagnostic method, biomarker and kit for early detection and staging of alzheimer's disease patent application.

###

Keyword Monitor How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like Serum diagnostic method, biomarker and kit for early detection and staging of alzheimer's disease or other areas of interest.
###


Previous Patent Application:
Method for detecting antibody against sith-1 in biological sample
Next Patent Application:
Testing efficacy for celiac disease
Industry Class:
Chemistry: molecular biology and microbiology
Thank you for viewing the Serum diagnostic method, biomarker and kit for early detection and staging of alzheimer's disease patent info.
- - -

Results in 0.10173 seconds


Other interesting Freshpatents.com categories:
Computers:  Graphics I/O Processors Dyn. Storage Static Storage Printers

###

Data source: patent applications published in the public domain by the United States Patent and Trademark Office (USPTO). Information published here is for research/educational purposes only. FreshPatents is not affiliated with the USPTO, assignee companies, inventors, law firms or other assignees. Patent applications, documents and images may contain trademarks of the respective companies/authors. FreshPatents is not responsible for the accuracy, validity or otherwise contents of these public document patent application filings. When possible a complete PDF is provided, however, in some cases the presented document/images is an abstract or sampling of the full patent application for display purposes. FreshPatents.com Terms/Support
-g2-0.2738

66.232.115.224
Browse patents:
Next
Prev

stats Patent Info
Application #
US 20120107841 A1
Publish Date
05/03/2012
Document #
13186017
File Date
07/19/2011
USPTO Class
435/792
Other USPTO Classes
5303891
International Class
/
Drawings
3


Mild Cognitive Impairment

Follow us on Twitter
twitter icon@FreshPatents



Chemistry: Molecular Biology And Microbiology   Measuring Or Testing Process Involving Enzymes Or Micro-organisms; Composition Or Test Strip Therefore; Processes Of Forming Such Composition Or Test Strip   Involving Antigen-antibody Binding, Specific Binding Protein Assay Or Specific Ligand-receptor Binding Assay   Assay In Which An Enzyme Present Is A Label   Heterogeneous Or Solid Phase Assay System (e.g., Elisa, Etc.)  

Browse patents:
Next
Prev
20120503|20120107841|serum diagnostic method, biomarker and kit for early detection and staging of alzheimer's disease|A laboratory method for screening, diagnosing, monitoring and/or staging early onset Alzheimer's disease which consists of mild cognitive impairment entails conducting a blood test after an oxidative exposure of serum to assay for the presence of an elevated level of redox-reactive autoantibodies. |
';